PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjcredLink to Publisher's site
 
Br Med J (Clin Res Ed). 1982 January 9; 284(6309): 73–76.
PMCID: PMC1495709

Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic shock after acute myocardial infarction.

Abstract

Nine patients with critically reduced cardiac output after acute myocardial infarction underwent a single cross-over comparison of dobutamine and salbutamol to compare the haemodynamic effects of these drugs, which have, respectively, predominantly beta 1-adrenergic and beta 2-adrenergic agonist activity. The responses were used to select the more appropriate treatment for individual patients. Only relatively small responses were obtained: those with poorest baseline measurements tended to show the least effect. When the results from the series were averaged, dobutamine (250-750 microgram/min) caused a small but progressive increase in cardiac index (1.8 to 2.2 1/min/m2) throughout the dose range. Systemic blood pressure was not increased, and calculated systemic vascular resistance fell from 25 to 19 units. Heart rate rose from 107 to 118 beats/min and stroke index from 17 to 19 ml/beat/m2. Pulmonary artery end-diastolic pressure fell from 18 to 15 mm Hg. Salbutamol (10-40 microgram/min) produced a similar progressive increase in cardiac index, from 1.6 to 2.21/min/m2. Systemic blood pressure was not altered, and systemic vascular resistance fell from 25 to 20 units. Heart rate rose from 105 to 119 beats/min and stroke index from 16 to 19 ml/beat/m2. Pulmonary artery end-diastolic pressure did not fall. Dobutamine and salbutamol have closely similar haemodynamic effects when used in cardiogenic shock after acute myocardial infarction. Both drugs increase cardiac index but heart rate also rises, and the increase in stroke index is relatively small. Mean arterial pressure is altered little by either agent, but dobutamine (in contrast with dopamine) tends to reduce pulmonary artery end-diastolic pressure, which may be beneficial.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (819K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Tuttle RR, Mills J. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res. 1975 Jan;36(1):185–196. [PubMed]
  • Jewitt D, Birkhead J, Mitchell A, Dollery C. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine. Lancet. 1974 Aug 17;2(7877):363–367. [PubMed]
  • Gillespie TA, Ambos HD, Sobel BE, Roberts R. Effects of dobutamine in patients with acute myocardial infarction. Am J Cardiol. 1977 Apr;39(4):588–594. [PubMed]
  • Goldstein RA, Passamani ER, Roberts R. A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure. N Engl J Med. 1980 Oct 9;303(15):846–850. [PubMed]
  • Stoner JD, 3rd, Bolen JL, Harrison DC. Comparison of dobutamine and dopamine in treatment of severe heart failure. Br Heart J. 1977 May;39(5):536–539. [PMC free article] [PubMed]
  • Leier CV, Heban PT, Huss P, Bush CA, Lewis RP. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation. 1978 Sep;58(3 Pt 1):466–475. [PubMed]
  • Timmis AD, Strak SK, Chamberlain DA. Haemodynamic effects of salbutamol in patients with acute myocardial infarction and severe left ventricular dysfunction. Br Med J. 1979 Nov 3;2(6198):1101–1103. [PMC free article] [PubMed]
  • Timmis AD, Fowler MB, Chamberlain DA. Comparison of haemodynamic responses to dopamine and salbutamol in severe cardiogenic shock complicating acute myocardial infarction. Br Med J (Clin Res Ed) 1981 Jan 3;282(6257):7–9. [PMC free article] [PubMed]
  • Yusuf S, Ramsdale D, Peto R, Furse L, Bennett D, Bray C, Sleight P. Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial. Lancet. 1980 Aug 9;2(8189):273–276. [PubMed]
  • Norris RM. Beta adrenoceptor blockade in acute myocardial infarction. Am Heart J. 1980 Jun;99(6):683–685. [PubMed]
  • Leinbach RC, Gold HK. Regional streptokinase in myocardial infarction. Circulation. 1981 Mar;63(3):498–499. [PubMed]

Articles from British Medical Journal (Clinical Research Ed.) are provided here courtesy of BMJ Publishing Group